Physician profile
Khalid S Aly
NPI 1952334955
$2,346.69
in general payments reported to CMS, 2019-2025
17 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,376 · 2020: $445 · 2021: $11.97 · 2022: $268 · 2024: $134 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $643.97 | 2019-2025 | Breztri |
| Novo Nordisk INC | $478.42 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $351.12 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.57 | 2019-2020 | |
| Amgen INC. | $143.10 | 2019-2022 | |
| Glaxosmithkline, LLC. | $90.60 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $85.96 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $83.71 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $69.19 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Astellas Pharma US INC | $67.91 | 2019 | |
| Lilly USA, LLC | $62.22 | 2019-2022 | |
| Pfizer INC. | $29.89 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.02 | 2020 | |
| Abbott Laboratories | $19.07 | 2022 | |
| Mylan Specialty L.P. | $16.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $13.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Aly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.